27 January 2012 Business
Industry news, February 2012
Generic drugs heavyweight Actavis is selling off a subsidiary based in Foshan, China. The business is being bought by Zhejiang Chiral Medicine Chemicals for an undisclosed sum.
In a company statement, Actavis stressed that the company ‘intends to continue further commercial operations in
24 August 2014 Research
Scientists hope that biotech route could protect the drug supply chain from harvest failures and problems with illicit use
23 July 2014 Comments
Giving the world carbon-free energy means putting nuclear energy back on the agenda, says James Hansen